Can Pulmonary Vascular Resistance Predict Response to Cardiac Resynchronization Therapy in Patients with Heart Failure?

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 10, 2015-10 ,pp. : 1210-1216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 10, 2015-10 ,pp. : 1066-1074

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urgent Cardiac Resynchronization Therapy in Patients with Decompensated Chronic Heart Failure Receiving Inotropic Therapy

By  

Cardiology, Vol. 106, Iss. 1, 2006-07 ,pp. : 59-62

Karger

Access to resources Recommend Favorite

Impact of Pacing Site on QRS Duration and Its Relationship to Hemodynamic Response in Cardiac Resynchronization Therapy for Congestive Heart Failure

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 25, Iss. 9, 2014-09 ,pp. : 1012-1020

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 135-143

John Wiley & Sons Inc

Access to resources Recommend Favorite